Here are 19 key notes from spine and orthopedic device companies this week.
Bacterin achieved coverage from Medicare Administrative Contractor Novitas Solutions for the Accellular Dermal Matrix allograft.
The first spine surgery using Aurora Spine's ZIP 51 Minimally Invasive Interspinous Implant was completed in the United States and Germany.
Bone Therapeutics reported several ongoing trials in 2014 as well as an operating income that increased 8 percent over 2013.
Boston Scientific has collaborated with Brainlab, a software-driven medical technology company.
Centene appointed Ken Yamaguchi, MD, executive vice president and CMO, effective immediately.
Ceterix Orthopaedics received a Silver award at the 2015 Edison Awards in the surgical tools category to recognize the "best and brightest in innovation, creativity and ingenuity in the global economy."
CyMedica Orthopedics launched the CyMedica QB1 System for quadriceps muscle atrophy.
The biggest orthopedic device companies in the market today are DePuy Synthes, Stryker, Zimmer and Medtronic, according to a new Kalorama Information report.
DJO Global reported early tender results for their exchange offer and consent solicitation with respect to senior subordinated notes.
Exactech's first quarter 2015 net income was down 2 percent to $4.1 million.
Haemonetics reported a lower fourth quarter revenue for the 2015 fiscal year — revenue was down 6 percent, reaching only $226.5 million for the fourth quarter.
Implanet first quarter revenue was down 21 percent in the first quarter of 2015.
Invuity filed to undertake an initial public offering to raise $69 million.
Mazor Robotics' guidance system — Renaissance and the earlier Spine Assist — has been successfully used in 10,000 spinal surgeries.
Misonix entered into an exclusive national supply contract with MedAssets.
NuVasive reached an agreement and will pay $13.8 million to the U.S. Department of Justice related to the subpoena for from the Office of the Inspector General of the Department of Health and Human Services issued in 2013.
Orthofix reported the fourth quarter 2014 and fiscal year financial results — Net sales were down 5.3 percent to $100.3 million.
St. Jude Medical intends to acquire Spinal Modulation.
Zimmer's net sales in the first quarter 2015 were $1.13 billion, which was a 2.3 percent decrease, a 2.3 percent decrease over the same period last year.